IM Cannabis Announces Pricing of US$1.31 Million Registered Direct Offering of Common Shares

IM Cannabis Announces Pricing of US$1.31 Million Registered Direct Offering of Common Shares PR Newswire

VANCOUVER, BC and GLIL YAM, Israel, Sept. 23, 2026 /PRNewswire/ -- IM Cannabis Corp. ("IMCC" or the "Company") (Nasdaq: IMCC), a medical cannabis company with operations in Israel and Germany, today announced that it has entered into securities purchase agreements with certain accredited investors for the purchase and sale of 655,000 common shares, no par value per share, at a purchase price of US$2.00 per share, pursuant to a registered direct offering, resulting in gross proceeds of approximately US$1.31 million at closing before offering expenses. The closing of the offering is expected to occur on or about September 24, 2026, subject to the satisfaction of customary closing conditions.